Discover the top digital transformation trends in health systems for 2025, including accelerated adoption of virtual health and increasing cyberattacks.

In a healthcare market brimming with potential, DarioHealth Corp. * is quietly emerging as a standout player, combining cutting-edge technology with proven outcomes. Looking at recent achievements, it ...

An Orlando-based 503B pharmaceutical company is now serving clients in Alabama. Olympia Pharmaceuticals, an FDA-registered ...

Discover the FDA-approved indications for GLP-1 receptors, including diabetes, weight loss, and cardiovascular disease. Learn brand-name and generic options.

Kenox Pharmaceuticals Inc., a company dedicated to developing innovative Orally Inhaled and Nasal Drug Products (OINDPs), has ...

Robert F. Kennedy Jr. is set to appear before the Senate Finance Committee for the first of two confirmation hearings as Trump’s nominee for health secretary.

Kenox Pharmaceuticals Inc (Kenox), a fast-growing company dedicated to developing innovative Orally Inhaled and Nasal Drug Products (OINDPs), is proud to announce the addition of small scale ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Join a suite of experts from across the industry Jan. 29 for a free online event examining the opportunities and challenges ...

Allurion, while battling declining revenues, is targeting the loss in muscle mass seen in patients on GLP-1RA therapy.

Truist Securities, TD Cowen, Citigroup Inc. ( C) and Canaccord Genuity all also rate BSX "buy," while JPMorgan Chase & Co. ( ...

Allurion Technologies (NYSE: ALUR) shares are moving higher Friday potentially after after the company announced plans to ...